← FDA DRUG APPROVALS

FDA ANDA · ANDA087104

FLUOCINOLONE ACETONIDE

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA087104
TYPE
ANDA
ORIGINAL APPROVAL
1982-04-27
LATEST ACTION
1996-07-31
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued

Products

FLUOCINOLONE ACETONIDEDiscontinued
FLUOCINOLONE ACETONIDE 0.025% · CREAM · TOPICAL

Approval history

1996-07-31Labeling · Supplement 30AP
1993-03-29Labeling · Supplement 28AP
1992-11-16Labeling · Supplement 27AP
1991-02-11Labeling · Supplement 24AP
1991-02-11Labeling · Supplement 25AP
1990-01-19Labeling · Supplement 23AP
1990-01-03Manufacturing (CMC) · Supplement 21AP
1989-02-16Labeling · Supplement 20AP
1986-10-07Manufacturing (CMC) · Supplement 13AP
1985-09-13Manufacturing (CMC) · Supplement 9AP
1984-06-12Manufacturing (CMC) · Supplement 6AP
1983-06-09Manufacturing (CMC) · Supplement 4AP
1982-12-30Manufacturing (CMC) · Supplement 3AP
1982-04-27OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →